Corinaldesi, C, El-Sherbiny, YM, Migneco, G et al. (4 more authors) (2018) CBS004, a Novel Monoclonal Antibody Against Bdca-2 Inhibits TLR-Induced Activation of Human pDC in Vitro and In Vivo. a Novel Therapeutic Target for Systemic Sclerosis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL. Wiley
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Keywords: | Dendritic cells; interferons; monoclonal antibodies; mouse model and systemic sclerosis |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Infection and Immunity (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds) |
Funding Information: | Funder Grant number Capella Bioscience Ltd NOEXT REF GIVEN |
Depositing User: | Symplectic Publications |
Date Deposited: | 25 Jun 2019 14:01 |
Last Modified: | 25 Jun 2019 14:01 |
Status: | Published |
Publisher: | Wiley |
Identification Number: | 10.1002/art.40700 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:147699 |